Literature DB >> 24978361

Impact of active surveillance on pathology and nerve sparing status.

Rachael Sussman1, Ilene Staff, Joseph Tortora, Alison Champagne, Anoop Meraney, Stuart S Kesler, Joseph R Wagner.   

Abstract

INTRODUCTION: We assessed whether, in comparison to immediate surgery, a time delay in performing radical prostatectomy (RP) in patients electing to undergo a period of active surveillance (AS) of low grade prostate cancer, is associated with adverse pathologic features, biochemical recurrence and the ability to perform effective nerve sparing surgery.
MATERIALS AND METHODS: From our RP database of 2769 patients, we identified 41 men under AS who subsequently underwent RP. This study group was compared to control group A (164 patients who chose RP rather than AS), matched for prostate-specific antigen (PSA) and initial diagnostic biopsy characteristics. With time, PSA and biopsy characteristics in the AS study group changed, prompting these men to undergo RP. These changes were matched to create a separate control group B (123 patients most of whom did not meet AS criteria). The incidence of nerve sparing surgery, pathologic features, and biochemical recurrence were compared. Outcome variables were compared using Chi-square tests of proportions. Fisher's Exact test was used for recurrence rates due to the low expected frequencies in some cells.
RESULTS: Compared with control group A, the AS patients experienced higher rates of Gleason score upgrading (33/41; 81.1% versus 76/164; 46.3%, p < 0.001), biochemical recurrence (5/41; 11.4% versus 2/164; 1.3%, p = 0.012) and lower rates of bilateral nerve sparing surgery (31/41; 75.6% versus 154/164; 93.9%, p < 0.001). Control group B and active surveillance group were comparable across all indices measured.
CONCLUSIONS: Delaying RP, through undergoing a period of AS, had a significant negative impact on the incidence of bilateral nerve sparing surgery and adverse pathologic features when compared to patients with similar parameters at the time of diagnosis. Close monitoring and surveillance biopsies did not improve pathologic outcomes compared to patients from whom a single diagnostic biopsy was obtained (and were not candidates for AS), and who subsequently underwent immediate surgery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24978361

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  2 in total

1.  Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.

Authors:  Kazuhisa Hagiwara; Yuki Tobisawa; Takatoshi Kaya; Tomonori Kaneko; Shingo Hatakeyama; Kazuyuki Mori; Yasuhiro Hashimoto; Takuya Koie; Yoshihiko Suda; Chikara Ohyama; Tohru Yoneyama
Journal:  Int J Mol Sci       Date:  2017-01-26       Impact factor: 5.923

2.  Clinical significance of the LacdiNAc-glycosylated prostate-specific antigen assay for prostate cancer detection.

Authors:  Tohru Yoneyama; Yuki Tobisawa; Tomonori Kaneko; Takatoshi Kaya; Shingo Hatakeyama; Kazuyuki Mori; Mihoko Sutoh Yoneyama; Teppei Okubo; Koji Mitsuzuka; Wilhelmina Duivenvoorden; Jehonathan H Pinthus; Yasuhiro Hashimoto; Akihiro Ito; Takuya Koie; Yoshihiko Suda; Robert A Gardiner; Chikara Ohyama
Journal:  Cancer Sci       Date:  2019-06-27       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.